WHO ICTRP trial
Pre-exposure prophylaxis with on-demand versus daily TDF/FTC in men who have sex…
ChiCTR1800016100 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800016100 |
|---|---|
| Public title | Pre-exposure prophylaxis with on-demand versus daily TDF/FTC in men who have sex with men at high risk of HIV infection – a crossover study |
| Scientific title | Pre-exposure prophylaxis with on-demand versus daily TDF/FTC in men who have sex with men at high risk of HIV infection – a crossover study |
| Primary sponsor | Stanley Ho Centre for Emerging Infectious Diseases |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | HIV infection |
| Interventions | Two groups:Truvada tablet (Tenofovir 300 mg / Emtricitabine 200 mg): 1 tablet daily versus 2 tablets before sex, and 1 tablet at 24 and then 48 hours afterwards, for 16 weeks |
| Registration date | May 11, 2018 |
| Target size | Two groups:90 |
| Secondary IDs | CUHK_CCRB00606 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: